Letter by Nielsen and Søgaard Regarding Article, “Rivaroxaban Versus Apixaban for Stroke Prevention in Atrial Fibrillation: An Instrumental Variable Analysis of a Nationwide Cohort”
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.